መነሻ › Metastatic Cancer › አዮዋ
በአዮዋ ለMetastatic Cancer የሚደረጉ ክሊኒካዊ ጥናቶች
ለMetastatic Cancer የሚደረጉ 10 ጥናቶች በአዮዋ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በአዮዋ ውስጥ ያሉ ከተሞች
Official study text (English)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
- እና 4 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05564377A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Des Moines
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06103864A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- University of Iowa, Iowa City
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07174336A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- University of Iowa, Iowa City
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT07029399A Study of ASP1002 in Adults for Treatment of Solid Tumors
- University of Iowa Hospitals, Iowa City
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ጁላይ 2026 · NCT05719558Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- University of Iowa Health Care, Iowa City
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ጁን 2026 · NCT052833305-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors
- University of Iowa Health Care, Iowa City
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ18 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሜይ 2026 · NCT07404332A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- University of Iowa, Iowa City
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኤፕሪ 2026 · NCT06581406Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
- University of Iowa Hospitals & Clinics- Holden Comprehensive Cancer Center, Iowa City
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ፌብሩ 2026 · NCT06127407SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Iowa City
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።